Richard Shea
Directeur/Membre du Conseil chez SYNLOGIC, INC.
Fortune : 750 $ au 30/06/2024
Profil
Richard P.
Shea is currently serving as a Director at Synlogic Operating Co., Inc., an Independent Director at Synlogic, Inc., and a Principle at Danforth Advisors LLC.
Previously, he held positions as Vice President-Finance at Genetics Institute LLC from 1992 to 1999, Chief Financial Officer & Senior Vice President at Momenta Pharmaceuticals, Inc. from 2015 to 2016, CFO, Treasurer & Principal Accounting Officer at Syndax Pharmaceuticals, Inc. from 2017 to 2020, and Chief Operating & Financial Officer at Variagenics, Inc. from 1999 to 2003.
Mr. Shea obtained an MBA from Boston University and completed his undergraduate studies at Princeton University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SYNLOGIC INC
0,00% | 31/03/2024 | 500 ( 0,00% ) | 750 $ | 30/06/2024 |
Postes actifs de Richard Shea
| Sociétés | Poste | Début |
|---|---|---|
| SYNLOGIC, INC. | Directeur/Membre du Conseil | 28/08/2017 |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Danforth Advisors LLC
 Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA. | Corporate Officer/Principal | - |
Anciens postes connus de Richard Shea
| Sociétés | Poste | Fin |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Directeur Financier/CFO | 13/07/2020 |
| MOMENTA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/12/2016 |
Variagenics, Inc.
 Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Variagenics, Inc. develops molecular diagnostic tests by identifying genetic markers associated with response to cancer therapies, with the goal of optimizing patient care through both biopharmaceutical collaborations and its own internal research programs | Directeur Financier/CFO | 01/04/2003 |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Directeur Financier/CFO | 01/01/1999 |
Formation de Richard Shea
| Boston University | Masters Business Admin |
| Princeton University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Health Technology |
| SYNLOGIC, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Variagenics, Inc.
Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Variagenics, Inc. develops molecular diagnostic tests by identifying genetic markers associated with response to cancer therapies, with the goal of optimizing patient care through both biopharmaceutical collaborations and its own internal research programs | Commercial Services |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Danforth Advisors LLC
Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA. | Commercial Services |
